NYSE:CLBCore Laboratories Stock Price, Forecast & News

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CLB shares have increased by 84.6% and is now trading at $20.18. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Core Laboratories.

Core Laboratories will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Wednesday, April, 22nd. The oil and gas company reported $0.31 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.33 by $0.02. The oil and gas company earned $152.40 million during the quarter, compared to the consensus estimate of $151.37 million. Core Laboratories had a negative net margin of 7.21% and a positive return on equity of 46.28%. The company's quarterly revenue was down 9.9% on a year-over-year basis. During the same quarter last year, the business earned $0.44 EPS. View Core Laboratories' earnings history.

Core Laboratories declared a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 19th. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date is Thursday, May 7th. View Core Laboratories' dividend history.

14 brokers have issued 1 year target prices for Core Laboratories' stock. Their forecasts range from $7.50 to $48.00. On average, they expect Core Laboratories' share price to reach $24.81 in the next twelve months. This suggests a possible upside of 22.9% from the stock's current price. View analysts' price targets for Core Laboratories.

Press coverage about CLB stock has trended very negative recently, according to InfoTrie. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Core Laboratories earned a news impact score of -3.2 on InfoTrie's scale. They also assigned media headlines about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Core Laboratories.

Core Laboratories saw a increase in short interest in June. As of June 30th, there was short interest totaling 8,250,000 shares, an increase of 14.1% from the June 15th total of 7,230,000 shares. Based on an average trading volume of 1,580,000 shares, the short-interest ratio is currently 5.2 days. Currently, 18.8% of the shares of the company are short sold. View Core Laboratories' Current Options Chain.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), National Energy Services Reunited (NESR), Helix Energy Solutions Group (HLX), Franks International (FI), NexTier Oilfield Solutions (NEX), Propetro (PUMP), Select Energy Services (WTTR), Keane Group (FRAC), Key Energy Services (KEGX), North American Construction Group (NOA), Hurricane Energy (HRCXF) and Natural Gas Services Group (NGS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.07%), Everence Capital Management Inc. (0.03%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories.

CLB stock was bought by a variety of institutional investors in the last quarter, including Everence Capital Management Inc., Envestnet Asset Management Inc., and Louisiana State Employees Retirement System. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $20.18.

Core Laboratories has a market capitalization of $897.14 million and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]